FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31

Fortrea Holdings Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026

$22.42−0.07 (-0.31%)

Close on Oct 19, 2026

Market cap: $2.13B
P/E (TTM): –
Dividend yield: –

Dividends

Fortrea has not reported a dividend

No dividend per share appears in Fortrea's annual filings since fiscal 2020.

Where these numbers come from

Parsed from the XBRL in Fortrea's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is FTRE.

Revenue growth-2.1% · median 37.8%

Gross margin19.3% · median 35.6%

Operating margin-0.4% · median -10.7%

Net margin-3.2% · median -7.1%

Company	Revenue	Growth
LH	$14.35B	+6.4%
NTRA	$2.71B	+37.8%
FTRE	$2.68B	-2.1%
GH	$1.18B	+42.7%
CAI	$989.61M	+85.4%
FLGT	$323.93M	+6.8%

Company

Next earnings (est.): Nov 4, 2026, before open
Exchange: Nasdaq
Industry: Services-Medical Laboratories
Fiscal year ends: December 31
Employees: 14,300
Held by institutions: 100.0%
Auditor: Deloitte & Touche LLP
SEC CIK: 1965040

Advertisement
300 × 250